The Role of Cryotherapy in Vitreous Concentrations of Topotecan Delivered by Episcleral Hydrogel Implant.
HEMA
episcleral implant
hydrogel
intraocular delivery
periocular delivery
retina
retinoblastoma
topotecan
transconjunctival cryotherapy
transscleral diffusion
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
20 Apr 2022
20 Apr 2022
Historique:
received:
28
02
2022
revised:
13
04
2022
accepted:
18
04
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Transscleral diffusion delivery of chemotherapy is a promising way to reach the vitreal seeds of retinoblastoma, the most common intraocular malignancy in childhood. In this
Identifiants
pubmed: 35631489
pii: pharmaceutics14050903
doi: 10.3390/pharmaceutics14050903
pmc: PMC9144907
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Retina. 2016 Jun;36(6):1184-90
pubmed: 26630319
Retina. 2017 Jan;37(1):1-10
pubmed: 27617542
Prog Retin Eye Res. 2019 Nov;73:100764
pubmed: 31173880
J Control Release. 2010 Nov 20;148(1):42-48
pubmed: 20831888
Exp Eye Res. 2013 Mar;108:103-9
pubmed: 23333535
Exp Eye Res. 2006 Mar;82(3):479-87
pubmed: 16168412
Colloids Surf B Biointerfaces. 2016 Oct 1;146:624-31
pubmed: 27429296
Onco Targets Ther. 2020 May 08;13:3903-3920
pubmed: 32440155
Mater Sci Eng C Mater Biol Appl. 2019 Oct;103:109799
pubmed: 31349439
Br J Ophthalmol. 2012 Aug;96(8):1078-83
pubmed: 22694968
Retina. 2000;20(4):346-57
pubmed: 10950411
Invest Ophthalmol Vis Sci. 2007 May;48(5):2230-7
pubmed: 17460284
Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3761-7
pubmed: 17652749
J Pharm Sci. 2015 Jul;104(7):2190-202
pubmed: 25973792
Ophthalmic Genet. 2014 Dec;35(4):193-207
pubmed: 25321846
J Control Release. 2017 Oct 28;264:34-44
pubmed: 28830790
Br J Ophthalmol. 2022 Feb;106(2):288-296
pubmed: 33972235
Indian J Ophthalmol. 2020 Nov;68(11):2356-2365
pubmed: 33120616
Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5403-20
pubmed: 20980702
Ophthalmology. 2017 Apr;124(4):488-495
pubmed: 28089679
Pharm Res. 2009 May;26(5):1155-61
pubmed: 19194787
Br J Ophthalmol. 2012 Aug;96(8):1084-7
pubmed: 22368262
Am J Ophthalmol. 1989 Sep 15;108(3):260-4
pubmed: 2774035
JAMA Ophthalmol. 2017 Dec 1;135(12):1426-1429
pubmed: 29098285
Exp Eye Res. 2021 Mar;204:108423
pubmed: 33453276
Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4532-9
pubmed: 17003449
Exp Eye Res. 2022 May;218:109026
pubmed: 35276184
Ophthalmology. 2004 May;111(5):984-91
pubmed: 15121378
Retina. 1997;17(4):338-43
pubmed: 9279951
Arch Ophthalmol. 1982 Aug;100(8):1253-6
pubmed: 7103809
Arch Ophthalmol. 1996 Nov;114(11):1390-5
pubmed: 8906030
Onco Targets Ther. 2019 Jul 30;12:6069-6082
pubmed: 31534347
Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2126-34
pubmed: 19834044
J AAPOS. 2000 Dec;4(6):334-7
pubmed: 11124666
Adv Drug Deliv Rev. 2018 Feb 15;126:96-112
pubmed: 28916492
Arch Ophthalmol. 2011 Jun;129(6):738-45
pubmed: 21670340
Ophthalmology. 2014 Sep;121(9):1810-7
pubmed: 24819859
Am J Ophthalmol. 2000 Jun;129(6):817-9
pubmed: 10927003
Invest Ophthalmol Vis Sci. 2008 Feb;49(2):490-6
pubmed: 18234990
Ophthalmic Res. 2007;39(5):244-54
pubmed: 17851264
JAMA Ophthalmol. 2014 Aug;132(8):936-41
pubmed: 24789622
Int J Pharm. 2021 Sep 5;606:120832
pubmed: 34175379
J Ocul Pharmacol Ther. 2008 Aug;24(4):385-91
pubmed: 18665810
J AAPOS. 2018 Jun;22(3):235-237.e2
pubmed: 29698780
Drug Discov Today. 2019 Aug;24(8):1458-1469
pubmed: 30930148
Drug Discov Today. 2011 Mar;16(5-6):270-7
pubmed: 21167306
Acta Biomater. 2014 Jan;10(1):126-33
pubmed: 24076072